Patty H. Kiang, Ph.D. is a Pharmaceutical Consultant on Pharmaceutical packaging and delivery devices for liquid and lyophilized products, Prefilled syringe system, and CMC filing for Combination Products. Prior to the consultant position, she was Account Director for Catalent Pharma Solutions; she was responsible for business development of Analytical & Biotech Services to Biotech and Pharmaceutical companies on the West Coast of USA, Canada and Asia Pacific territory.

She was Head of Device Development for Genentech, Inc. in South San Francisco, CA. She was responsible for the development of a new autopen injector for Growth Hormone; she was also responsible for setting up the Extractable / Leachable program for evaluation of primary container/closure systems and was a CMC leader for a prefilled syringe drug development. Prior to joining Genentech, she was Director, Delivery Device and Packaging Support for Schering Plough, in Kenilworth, NJ. She was responsible for the development of PEG-Interferon dual chamber pen injector and various delivery devices. Prior to joining Schering Plough, she was Director of Technology Development for West Pharmaceutical Services in Lionville, PA, a developer and manufacturer of parenteral drug packaging components, where she coordinated with corporate partners in Japan and Germany in the development of various new products.

She is a member of the faculty of the PDA’s Training and Research Institute, where she teaches courses on Parenteral Packaging, Prefilled Syringe and Injection Devices, and served as a member of USP’s Expert Committee on Drug Packaging, Storage and Distribution. She was the chairperson for PDA Gamma Radiation Sterilization of Polymeric Materials Committee. She is an expert in the area of drug and container/closure interactions and compability issues.